Dr. Jim Doherty is Chief Research Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Jim and his colleagues are focused on developing new treatments for different brain disorders including psychiatric, neurodegenerative, and movement disorders. Outside of science, Jim enjoys traveling, seeing cool new sites, and exploring the history of different places with his wife and two kids. He also enjoys participating in a variety of team sports like golf, softball, and ultimate frisbee leagues. Jim received his B.A. in biology from the University of Delaware and his Ph.D. in neuroscience from Georgetown University. Next, he conducted postdoctoral research at Emory University Medical School and subsequently served on the faculty at Emory for about two years. Prior to joining the team at Sage in 2014, Jim worked for about eleven years at AstraZeneca Pharmaceuticals. In our interview Jim shares more about his life and science.